Incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression: the VINTAGE study
Cytomegalovirus (CMV) infection is a frequent complication following kidney transplantation that affects transplant outcomes. This study aimed to (i) estimate the 12-month cumulative incidence of CMV antigenemia (AG) in adult kidney transplant recipients not receiving antiviral prophylaxis, (ii) ide...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2491658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850156545585709056 |
|---|---|
| author | Sumi Hidaka Kazunari Tanabe Shuzo Kobayashi |
| author_facet | Sumi Hidaka Kazunari Tanabe Shuzo Kobayashi |
| author_sort | Sumi Hidaka |
| collection | DOAJ |
| description | Cytomegalovirus (CMV) infection is a frequent complication following kidney transplantation that affects transplant outcomes. This study aimed to (i) estimate the 12-month cumulative incidence of CMV antigenemia (AG) in adult kidney transplant recipients not receiving antiviral prophylaxis, (ii) identify the risk factors for CMV AG, and (iii) assess the impact of CMV AG on transplant outcomes. This study included 128 living donor kidney recipients (aged ≥20 years) who underwent transplantation between 2012 and 2020. The mean recipient age was 52.8 ± 13.0 years. The overall positive CMV AG rates were 10.9%, 35.9%, 45.3%, 53.1%, and 59.4% (95% confidence interval (CI), 50.9–67.9) at 1, 2, 3, 6, and 12 months posttransplantation, respectively. The 12-month incidence rates in D−/R−, D−/R+, D+/R+, and D+/R − were 0%, 25.0%, 62.2%, and 81.3%, respectively. Multivariable analysis revealed that the risk of CMV AG increased with a stepwise increase in CMV serostatus risk category (hazard ratio (HR), 2.65; 95% CI, 1.66–4.21; p < .001) and recipient age (HR, 1.37 per 10-year increase; 95% CI, 1.14–1.65; p < .001). Positive CMV AG was associated with an increased risk of antibody-mediated rejection (HR, 21.40; 95% CI, 2.59–176.2; p = .005) and lower estimated glomerular filtration rate (p = .026). The risk of CMV AG is highest within the first 3 months posttransplant and persists for approximately 7–8 months in D + recipients. These findings underscore the importance of regular CMV monitoring for at least 6 months posttransplantation, particularly in centers employing preemptive therapy. |
| format | Article |
| id | doaj-art-8b06e5870def4fe79ca40b972da668f4 |
| institution | OA Journals |
| issn | 0886-022X 1525-6049 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Renal Failure |
| spelling | doaj-art-8b06e5870def4fe79ca40b972da668f42025-08-20T02:24:30ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492025-12-0147110.1080/0886022X.2025.2491658Incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression: the VINTAGE studySumi Hidaka0Kazunari Tanabe1Shuzo Kobayashi2Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, JapanKidney Transplant and Robotic Surgery Center, Shonan Kamakura General Hospital, Kanagawa, JapanKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kanagawa, JapanCytomegalovirus (CMV) infection is a frequent complication following kidney transplantation that affects transplant outcomes. This study aimed to (i) estimate the 12-month cumulative incidence of CMV antigenemia (AG) in adult kidney transplant recipients not receiving antiviral prophylaxis, (ii) identify the risk factors for CMV AG, and (iii) assess the impact of CMV AG on transplant outcomes. This study included 128 living donor kidney recipients (aged ≥20 years) who underwent transplantation between 2012 and 2020. The mean recipient age was 52.8 ± 13.0 years. The overall positive CMV AG rates were 10.9%, 35.9%, 45.3%, 53.1%, and 59.4% (95% confidence interval (CI), 50.9–67.9) at 1, 2, 3, 6, and 12 months posttransplantation, respectively. The 12-month incidence rates in D−/R−, D−/R+, D+/R+, and D+/R − were 0%, 25.0%, 62.2%, and 81.3%, respectively. Multivariable analysis revealed that the risk of CMV AG increased with a stepwise increase in CMV serostatus risk category (hazard ratio (HR), 2.65; 95% CI, 1.66–4.21; p < .001) and recipient age (HR, 1.37 per 10-year increase; 95% CI, 1.14–1.65; p < .001). Positive CMV AG was associated with an increased risk of antibody-mediated rejection (HR, 21.40; 95% CI, 2.59–176.2; p = .005) and lower estimated glomerular filtration rate (p = .026). The risk of CMV AG is highest within the first 3 months posttransplant and persists for approximately 7–8 months in D + recipients. These findings underscore the importance of regular CMV monitoring for at least 6 months posttransplantation, particularly in centers employing preemptive therapy.https://www.tandfonline.com/doi/10.1080/0886022X.2025.2491658Kidney transplantationcytomegalovirusdesensitizationdiabetic nephropathyolder recipients |
| spellingShingle | Sumi Hidaka Kazunari Tanabe Shuzo Kobayashi Incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression: the VINTAGE study Renal Failure Kidney transplantation cytomegalovirus desensitization diabetic nephropathy older recipients |
| title | Incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression: the VINTAGE study |
| title_full | Incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression: the VINTAGE study |
| title_fullStr | Incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression: the VINTAGE study |
| title_full_unstemmed | Incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression: the VINTAGE study |
| title_short | Incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression: the VINTAGE study |
| title_sort | incidence of cytomegalovirus infection after kidney transplantation in the modern era of immunosuppression the vintage study |
| topic | Kidney transplantation cytomegalovirus desensitization diabetic nephropathy older recipients |
| url | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2491658 |
| work_keys_str_mv | AT sumihidaka incidenceofcytomegalovirusinfectionafterkidneytransplantationinthemoderneraofimmunosuppressionthevintagestudy AT kazunaritanabe incidenceofcytomegalovirusinfectionafterkidneytransplantationinthemoderneraofimmunosuppressionthevintagestudy AT shuzokobayashi incidenceofcytomegalovirusinfectionafterkidneytransplantationinthemoderneraofimmunosuppressionthevintagestudy |